Innovative drug concept remains active, Shanghai Yizhong rises by 20%.

The concept of innovative drugs remains active, with Shanghai Yizhong hitting the 20% daily limit up, Nanxin Pharmaceutical rising over 16%, Dongcheng Pharmaceutical also hitting the daily limit, Chenxin Pharmaceutical with three consecutive daily limit ups, Huaren Double Crane, and Asia Pacific Pharmaceutical all experiencing large gains.